Is mannitol combined with furosemide a new treatment for refractory lymphedema? A case report

doi:10.12998/wjcc.v9.i29.8804

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 29

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4382)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

245

WORD

HTML

2539

Figures (1-3)

228

Tables (1-2)

238

Sum=3332

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

364

Download

686

Sum=1050

Oct 16, 2021 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Oct 16, 2021; 9(29): 8804-8811
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8804

Full Size Figure Download Figure

Figure 3 Changes in lymphedema during the hospital day. A: After discontinuation of mannitol and furosemide (on the 49^th hospital day); B: Improved lymphedema after reinstatement of mannitol and furosemide (on the 61^st hospital day).

Citation: Kim HS, Lee JY, Jung JW, Lee KH, Kim MJ, Park SB. Is mannitol combined with furosemide a new treatment for refractory lymphedema? A case report. World J Clin Cases 2021; 9(29): 8804-8811
URL: https://www.wjgnet.com/2307-8960/full/v9/i29/8804.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i29.8804